← FDA Drug Approvals (Drugs@FDA)

EXELON

NDA · New Drug Application · Sponsor: NOVARTIS · Approved 2000-04-21

Drug application

FDA Application #

NDA021025

Application type

New Drug Application

Brand name

EXELON

Generic name

Rivastigmine Tartrate

Active ingredients

RIVASTIGMINE TARTRATE

Dosage form

SOLUTION

Route

ORAL

Marketing status

Discontinued

Sponsor

NOVARTIS

First approval

2000-04-21

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown